OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ESR1 dysfunction triggers neuroinflammation as a critical upstream causative factor of the Alzheimer’s disease process
Junying Liu, Shouli Yuan, Xinhui Niu, et al.
Aging (2022) Vol. 14, Iss. 21, pp. 8595-8614
Open Access | Times Cited: 20

Showing 20 citing articles:

Emerging Evidence on Membrane Estrogen Receptors as Novel Therapeutic Targets for Central Nervous System Pathologies
Agnieszka Wnuk, Karolina Przepiórska, Bernadeta Angelika Pietrzak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4043-4043
Open Access | Times Cited: 23

Plasma miRNAs across the Alzheimer's disease continuum: Relationship to central biomarkers
Shiwei Liu, Tamina Park, D. Krüger, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 11, pp. 7698-7714
Open Access | Times Cited: 5

Study of the Anti-Inflammatory Mechanism of β-Carotene Based on Network Pharmacology
Shilin Wu, Ran Chen, Jingyun Chen, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7540-7540
Open Access | Times Cited: 11

Evaluation of altered cell–cell communication between glia and neurons in the hippocampus of 3xTg‐AD mice at two time points
Tabea M. Soelter, Timothy C. Howton, Elizabeth Wilk, et al.
Journal of Cell Communication and Signaling (2025) Vol. 19, Iss. 1
Open Access

Risk of Alzheimer's disease in Down syndrome: Insights gained by multi‐omics
Hui‐Qi Qu, Yichuan Liu, John J. Connolly, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access

In Silico Pharmacological and Pharmacokinetic Study of Marmeline From Bael Fruit for the Treatment of Alzheimer’s Disease
Tassanee Ongtanasup, Onkamon Jampa, Nattawan Suwannakul, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2025) Vol. 2025, Iss. 1
Open Access

Tinospora cordifolia Extract Enhances Dextromethorphan Bioavailability: Implications for Alzheimer’s Disease
Praful Kumar Majhi, Samir Sayyad, Mahendra Gaur, et al.
ACS Omega (2024) Vol. 9, Iss. 22, pp. 23634-23648
Open Access | Times Cited: 2

Anti-amnesic and Neuroprotective Potential of Genistein Against Alzheimer’s Disease
Niraj Kumar Singh, Neeraj Verma, Jeetendra Kumar Gupta, et al.
Revista Brasileira de Farmacognosia (2023) Vol. 34, Iss. 1, pp. 80-92
Closed Access | Times Cited: 5

The molecular mechanisms of steroid hormone effects on cognitive function
Hai Duc Nguyen, Giang Huong Vu, Woong‐Ki Kim
Archives of Gerontology and Geriatrics (2024) Vol. 129, pp. 105684-105684
Open Access | Times Cited: 1

Evaluation of altered cell-cell communication between glia and neurons in the hippocampus of 3xTg-AD mice at two time points
Tabea M. Soelter, Timothy C. Howton, Elizabeth J. Wilk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Novel insights into the activating transcription factor 4 in Alzheimer’s disease and associated aging-related diseases: Mechanisms and therapeutic implications
Nan Zhang, Jianfei Nao, Shun Zhang, et al.
Frontiers in Neuroendocrinology (2024) Vol. 74, pp. 101144-101144
Closed Access

The identification of biomarkers for Alzheimer's disease using a systems biology approach based on lncRNA-circRNA-miRNA-mRNA ceRNA networks
Babak Sokouti
Computers in Biology and Medicine (2024) Vol. 179, pp. 108860-108860
Closed Access

Network Pharmacology and Molecular Docking Perspectives into Lignans for Alzheimer's Disease Treatment
Seda Şirin, Serap Niğdelioğlu Dolanbay
Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi (2024)
Open Access

Scoulerine: A natural isoquinoline alkaloid targeting SLC6A3 to treat RCC
T. L. Qu, Yu Sun, Zhao Jingying, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117524-117524
Open Access

Page 1

Scroll to top